LETROZOLE AND METFORMIN VERSUS LETROZOLE ALONE FOR OVULATION INDUCTION IN WOMEN WITH POLYCYSTIC OVARIAN SYNDROME: A RANDOMISED CONTROLLED TRIAL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

PACTR

Registry ID

PACTR202202575907380

Enrollment

Registered

2022-02-03

Start date

2021-04-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fertility-female

Interventions

letrozole and metformin

letrozole

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: age 18-40. Normal seminal fluid analysis according to WHO cut off points within the past year. Hysterosalphingography finding of at least one patent tube. Clients should be willing and able to have timed intercourse.

Exclusion criteria

Exclusion criteria: BMI>35 Additional cause of infertility Ovarian disease Uterine fibroid Adenomyosis History of previous pelvic surgery Hyperprolactinaemia Thyroid disease

Design outcomes

Primary

Measure	Time frame
Ovulation rates	—

Secondary

Measure	Time frame
conception rates;Pregnancy rates	—

Countries

Nigeria

Contacts

Public ContactSumaila Shuaibu

Supervisor

sumailashuaibu@gmail.com+2348096765555

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026